Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

Worldwide, more than 55 million people suffer from dementia caused by Alzheimer's disease (AD) and other conditions that ...

The Herpes simplex virus hides in plain sight. For most, it’s a fleeting nuisance — a tingling lip, a blister, a cold sore.

Australia just approved the first new Alzheimer’s treatment in decades. But before patients get their hopes up, there’s a ...

A first-of-its-kind treatment to slow the symptoms of early Alzheimer's disease has been approved for use in Australia.The Therapeutic Goods Administration has registered pharmaceutical giant Eli ...

Serena Coleman, CQC deputy director of operations in the south, said in a report released on Friday that Share the Care ...

People with diabetes sometimes experience different symptoms during a stroke because of how high blood sugar affects the ...

Alzheimer’s researcher Donald Weaver tells The Conversation Weekly podcast what he’s learnt during more than 30 years of studying the disease.

Eli Lilly (LLY) stock in focus as the company beats Biogen (BIIB) to win regulatory nod in Australia for first ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...